CD226: a potent driver of antitumor immunity that needs to be maintained

被引：9

作者：

Bi, Jiacheng ^{[1
]}

机构：

[1] Chinese Acad Sci, Shenzhen Inst Synthet Biol, Shenzhen Inst Adv Technol, CAS Key Lab Quantitat Engn Biol, Shenzhen, Peoples R China

来源：

CELLULAR & MOLECULAR IMMUNOLOGY | 2022年 / 19卷 / 09期

基金：

国家重点研发计划;

关键词：

ACTIVATING RECEPTOR CD226; CELLS;

D O I：

10.1038/s41423-020-00633-0

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：969 / 970

页数：2

共 10 条

[1] Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy [J].

Blake, Stephen J. ;

Stannard, Kimberley ;

Liu, Jing ;

Allen, Stacey ;

Yong, Michelle C. R. ;

Mittal, Deepak ;

Aguilera, Amelia Roman ;

Miles, John J. ;

Lutzky, Viviana P. ;

de Andrade, Lucas Ferrari ;

Martinet, Ludovic ;

Colonna, Marco ;

Takeda, Kazuyoshi ;

Kuehnel, Florian ;

Gurlevik, Engin ;

Bernhardt, Guenter ;

Teng, Michele W. L. ;

Smyth, Mark J. .

CANCER DISCOVERY, 2016, 6 (04) :446-459

[2] CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells [J].

Braun, Matthias ;

Aguilera, Amelia Roman ;

Sundarrajan, Ashmitha ;

Corvino, Dillon ;

Stannard, Kimberley ;

Krumeich, Sophie ;

Das, Indrajit ;

Lima, Luize G. ;

Guzman, Lizeth G. Meza ;

Li, Kunlun ;

Li, Rui ;

Salim, Nazhifah ;

Jorge, Maria Villancanas ;

Ham, Sunyoung ;

Kelly, Gabrielle ;

Vari, Frank ;

Lepletier, Ailin ;

Raghavendra, Ashwini ;

Pearson, Sally ;

Madore, Jason ;

Jacquelin, Sebastien ;

Effern, Maike ;

Quine, Brodie ;

Koufariotis, Lambros T. ;

Casey, Mika ;

Nakamura, Kyohei ;

Seo, Eun Y. ;

Holzel, Michael ;

Geyer, Matthias ;

Kristiansen, Glen ;

Taheri, Touraj ;

Ahern, Elizabeth ;

Hughes, Brett G. M. ;

Wilmott, James S. ;

Long, Georgina V. ;

Scolyer, Richard A. ;

Batstone, Martin D. ;

Landsberg, Jennifer ;

Dietrich, Dimo ;

Pop, Oltin T. ;

Flatz, Lukas ;

Dougall, William C. ;

Veillette, Andre ;

Nicholson, Sandra E. ;

Moller, Andreas ;

Johnston, Robert J. ;

Martinet, Ludovic ;

Smyth, Mark J. ;

Bald, Tobias .

IMMUNITY, 2020, 53 (04) :805-+

[3] Targeting PVR (CD155) and its receptors in anti-tumor therapy [J].

Brlic, Paola Kucan ;

Rovis, Tihana Lenac ;

Cinamon, Guy ;

Tsukerman, Pini ;

Mandelboim, Ofer ;

Jonjic, Stipan .

CELLULAR & MOLECULAR IMMUNOLOGY, 2019, 16 (01) :40-52

[4] The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+ T Cell Effector Function [J].

Johnston, Robert J. ;

Comps-Agrar, Laetitia ;

Hackney, Jason ;

Yu, Xin ;

Huseni, Mahrukh ;

Yang, Yagai ;

Park, Summer ;

Javina, Vincent ;

Chiu, Henry ;

Irving, Bryan ;

Eaton, Dan L. ;

Grogan, Jane L. .

CANCER CELL, 2014, 26 (06) :923-937

[5] RETRACTED: CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms (Retracted article. See vol. 132, 2022) [J].

Li, Xian-Yang ;

Das, Indrajit ;

Lepletier, Ailin ;

Addala, Venkateswar ;

Bald, Tobias ;

Stannard, Kimberley ;

Barkauskas, Deborah ;

Liu, Jing ;

Aguilera, Amelia Roman ;

Takeda, Kazuyoshi ;

Braun, Matthias ;

Nakamura, Kyohei ;

Jacquelin, Sebastien ;

Lane, Steven W. ;

Teng, Michele W. L. ;

Dougall, William C. ;

Smyth, Mark J. .

JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (06) :2613-2625

[6] Balancing natural killer cell activation through paired receptors [J].

Martinet, Ludovic ;

Smyth, Mark J. .

NATURE REVIEWS IMMUNOLOGY, 2015, 15 (04) :243-254

[7] Interaction of cancer cells with platelets mediated by Necl-5/poliovirus receptor enhances cancer cell metastasis to the lungs [J].

Morimoto, K. ;

Satoh-Yamaguchi, K. ;

Hamaguchi, A. ;

Inoue, Y. ;

Takeuchi, M. ;

Okada, M. ;

Ikeda, W. ;

Takai, Y. ;

Imai, T. .

ONCOGENE, 2008, 27 (03) :264-273

[8] Tumor intrinsic and extrinsic immune functions of CD155 [J].

O'Donnell, Jake. S. ;

Madore, Jason ;

Li, Xian-Yang ;

Smyth, Mark J. .

SEMINARS IN CANCER BIOLOGY, 2020, 65 :189-196

[9] Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy [J].

Weulersse, Marianne ;

Asrir, Assia ;

Pichler, Andrea C. ;

Lemaitre, Lea ;

Braun, Matthias ;

Carrie, Nadege ;

Joubert, Marie-Veronique ;

Le Moine, Marie ;

Do Souto, Laura ;

Gaud, Guillaume ;

Das, Indrajit ;

Brauns, Elisa ;

Scarlata, Clara M. ;

Morandi, Elena ;

Sundarrajan, Ashmitha ;

Cuisinier, Marine ;

Buisson, Laure ;

Maheo, Sabrina ;

Kassem, Sahar ;

Agesta, Arantxa ;

Peres, Michael ;

Verhoeyen, Els ;

Martinez, Alejandra ;

Mazieres, Julien ;

Dupre, Loic ;

Gossye, Thomas ;

Pancaldi, Vera ;

Guillerey, Camille ;

Ayyoub, Maha ;

Dejean, Anne S. ;

Saoudi, Abdelhadi ;

Goriely, Stanislas ;

Avet-Loiseau, Herve ;

Bald, Tobias ;

Smyth, Mark J. ;

Martinet, Ludovic .

IMMUNITY, 2020, 53 (04) :824-+

[10] Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity [J].

Zhang, Qing ;

Bi, Jiacheng ;

Zheng, Xiaodong ;

Chen, Yongyan ;

Wang, Hua ;

Wu, Wenyong ;

Wang, Zhengguang ;

Wu, Qiang ;

Peng, Hui ;

Wei, Haiming ;

Sun, Rui ;

Tian, Zhigang .

NATURE IMMUNOLOGY, 2018, 19 (07) :723-+

← 1 →